# Hypotheses: Novel Cell States in Alzheimer's Disease via Standardized scRNA-seq Analysis
---
## Hypothesis 1: Iron-Regulated Microglial State Reveals Distinct Neurotoxic Subpopulation
**Description:** Standardized scRNA-seq processing will identify a microglial subpopulation characterized by iron metabolism gene signatures (FTH1, SLC40A1, FTL) that is enriched in AD brains and correlates with regional iron accumulation. This state represents a distinct trajectory from classical DAM, driven by sustained ferroptosis-like vulnerability rather than phagocytic clearance. Automated annotation frameworks will resolve this population by capturing co-expression of iron regulatory genes with reduced TREM2 independence.
**Target Gene/Protein:** SLC40A1 (ferroportin), FTH1 (ferritin heavy chain)
**Confidence Score:** 0.72
**Evidence:** Post-mortem studies demonstrate increased iron in AD substantia nigra and hippocampus (Dexter et al., 1991). Bulk RNA-seq from AD microglia shows upregulation of iron homeostasis genes. Mouse DAM data (Keren-Shaul et al., 2017) shows iron regulatory genes are modulated, but the iron-specific state has not been comprehensively characterized as a distinct cell identity in human AD.
---
## Hypothesis 2: Astrocyte Reactivity Gradient Confounds Current Binary Classifications
**Description:** Automated cell annotation will reveal that astrocyte populations in AD occupy a continuous gradient rather than discrete A1/A2 states. Specific coordinate positions on this gradient will correspond to proximity to amyloid plaques versus neurofibrillary tau pathology, suggesting that distinct molecular triggers (C3+ for synapses vs. GFAP+ for plaques) drive functionally different reactive phenotypes. Standardized processing will enable cross-study comparison to identify these gradients consistently.
**Target Gene/Protein:** GFAP, C3, SERPINA3N
**Confidence Score:** 0.78
**Evidence:** Single-nucleus studies (Mathys et al., 2019; Allen et al., 2022) show astrocyte heterogeneity but classify cells into broad categories. Work from Sofroniew and colleagues demonstrates astrocyte reactivity is stimulus-specific. Our hypothesis extends this by predicting gradient positions correlate with specific pathological burdens measurable via standardized pipelines.
---
## Hypothesis 3: Layer-Specific Excitatory Neuron Vulnerability Reveals Cortical Circuit Disruption Mechanisms
**Description:** Standardized scRNA-seq across prefrontal cortex and hippocampus will identify that specific excitatory neuron subtypes (L2/3 intratelencephalic neurons, L5/6 pyramidal tract neurons) show transcriptional signatures of integrated stress response activation that predict their dropout in AD. These vulnerable states will show downregulation of synaptic transmission genes and upregulation of ER stress markers (ATF4, CHOP) before cell loss, suggesting a window for intervention.
**Target Gene/Protein:** ATF4 (CREB2), CHOP (DDIT3), SYT1
**Confidence Score:** 0.81
**Evidence:** Human cortical neuron dropout in AD is layer-specific (Hof et al., 1996). Mouse models show layer 5 pyramidal neurons are vulnerable (Kobayashi et al., 2020). scRNA-seq studies show excitatory neurons show highest transcriptional changes in AD (Mathys et al., 2019). This hypothesis specifically predicts the vulnerable state signature that precedes death.
---
## Hypothesis 4: Novel Oligodendrocyte Precursor Cell (OPC) Maturation Block State in AD White Matter
**Description:** Automated annotation will identify a previously uncharacterized OPC state characterized by simultaneous expression of proliferation markers (PCNA, MKI67) and early differentiation markers (OLIG2, PDGFRA) alongside AD-risk genes (PLCG1, APOC1). This "maturation-stalled" state reflects failed remyelination attempts and correlates with white matter hyperintensities on MRI. Standardized processing will enable quantification of this state across cohorts.
**Target Gene/Protein:** PDGFRA, PLP1, APOC1
**Confidence Score:** 0.69
**Evidence:** AD brains show reduced myelin integrity (Bartzokis, 2004). OPCs are abundant in white matter and responsive to injury. APOE4 allele affects OPC function (Blanchard et al., 2022). No study has yet provided a unified characterization of OPC states across multiple AD brain regions using standardized approaches.
---
## Hypothesis 5: Automated Cell State Discovery Will Identify a Tau-Spreading Permissive Astrocyte State
**Description:** Cross-regional analysis will reveal an astrocyte subpopulation expressing genes that facilitate extracellular tau uptake and propagation (including HSPG-related genes and heparan sulfate biosynthesis genes). This state will be enriched in entorhinal cortex and hippocampus, correlating with early Braak staging. Standardized annotation will enable consistent identification across datasets, allowing validation of this cell type's role in staging propagation.
**Target Gene/Protein:** HSPG2 (perlecan), SDC3 (syndecan-3), HS3ST1
**Confidence Score:** 0.65
**Evidence:** Astrocytes can internalize tau via heparan sulfate proteoglycans (HSPG-mediated endocytosis) (Falzone et al., 2022). Regional vulnerability in entorhinal cortex is well-established in AD staging. However, no cell-state-specific analysis has identified the astrocyte population responsible for this function.
---
## Hypothesis 6: TREM2 Variant Carriers Show Truncated DAM Trajectory Revealing Critical Checkpoint Genes
**Description:** Standardized processing of AD brains stratified by TREM2 genotype will reveal that TREM2 risk variants produce a distinct microglial trajectory that stalls at an intermediate DAM state. Automated pseudotime analysis will identify the checkpoint genes that fail to activate, including late-DAM markers (AXL, CLEC7A). This will define a minimal gene set sufficient to drive full DAM transition, with therapeutic implications.
**Target Gene/Protein:** TREM2, AXL, CLEC7A, APOE
**Confidence Score:** 0.83
**Evidence:** TREM2 variants increase AD risk ~2-4 fold (Guerreiro et al., 2013). TREM2-deficient microglia show incomplete DAM transition (Keren-Shaul et al., 2017). Human AD brains with TREM2 variants show impaired microglial response (Singleton et al., 2022). This hypothesis extends these findings to predict the specific checkpoint genes defining the transition blockade.
---
## Hypothesis 7: Inhibitory Neuron Subtype Specific Vulnerability Reveals Excitation/Inhibition Imbalance Mechanism
**Description:** Standardized scRNA-seq will reveal that parvalbumin-positive (PV+) inhibitory interneurons show the earliest transcriptional stress signatures in AD, including downregulation of GABA synthesis enzymes (GAD1, GAD2) and calcium buffering proteins (PV, CALB1). This vulnerability state precedes amyloid plaque deposition in regional analyses, suggesting PV+ neuron dysfunction as a primary driver of circuit hyperexcitability rather than a consequence of pathology.
**Target Gene/Protein:** GAD1, GAD2, PVALB, KCNC2
**Confidence Score:** 0.75
**Evidence:** PV+ interneurons show early dysfunction in AD mouse models (Veres et al., 2019). GABAergic deficits correlate with cognitive impairment in AD patients (Loring et al., 2022). Human post-mortem studies show PV+ neuron reduction in AD cortex. This hypothesis predicts the precise transcriptional signature of this vulnerable state before morphological loss.
---
## Synthesis Notes
| Hypothesis | Primary Cell Type | Key Pathway | Novelty Level |
|------------|-------------------|-------------|---------------|
| H1 | Microglia | Iron homeostasis | High |
| H2 | Astrocytes | Reactivity states | Medium |
| H3 | Excitatory neurons | Integrated stress response | Medium |
| H4 | OPCs | Myelination failure | High |
| H5 | Astrocytes | Tau propagation | High |
| H6 | Microglia | DAM trajectory | Medium-High |
| H7 | Inhibitory neurons | GABAergic deficit | Medium |
**Feasibility Assessment:** Hypotheses 1, 2, 3, 6, and 7 can be tested using existing scRNA-seq datasets (AMP-AD, ROSMAP). Hypotheses 4 and 5 require prospective regional sampling and novel marker validation but offer the highest discovery potential.
**Standardization Impact:** The key value of standardized processing for these hypotheses lies in enabling cross-regional and cross-cohort comparison—critical for H2 (gradient vs. discrete states), H4 (white matter focus), and H5 (propagation staging).